Ottobock SE & Co. KGaA OBCK
XETR · Germany · Health Technology
€52.40-0.70 (-1.32%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Ottobock SE & Co KGaA (WBO:OBCK) reports 6.7% organic growth and raises EBITDA margin guidance to above 27%.
Change on the Management Board Following the Scheduled end of Stefan Heidenreich's Term of Office DUDERSTADT, GERMANY - June 24, 2026 (NEWMEDIAWIRE) - Ottobock SE & Co. KGaA, the listed global MedTech company, has appointed Dr. Katarzyna Mazur...
Despite robust earnings growth across European corporations, the region's stock markets have been under pressure due to geopolitical tensions and rising energy prices, which could lead to inflationary pressures and higher interest rates. In this environment, identifying stocks trading below their fair value can be a strategic approach for investors seeking opportunities amidst broader market uncertainties.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.